iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company's pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate utilizes multiplex polymerase chain reaction (mPCR) technology which is an integrated platform for automated sample preparation, amplification and detection preparation. The company also developing iCubate 2.0, an open platform that develops and markets mPCR assays. Its products are widely used in the treatment of infectious diseases. iCubate is headquartered in Huntsville, Alabama, the US .
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company iCubate Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- iCubate Inc Company Overview
- iCubate Inc Company Snapshot
- iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
- iCubate Inc - Pipeline Analysis Overview
- iCubate Inc - Key Facts
- iCubate Inc - Major Products and Services
- iCubate Inc Pipeline Products by Development Stage
- iCubate Inc Pipeline Products Overview
- iC-COVID19 Assay
- iC-COVID19 Assay Product Overview
- iC-GPC Assay
- iC-GPC Assay Product Overview
- iC-Myco Assay
- iC-Myco Assay Product Overview
- iCubate Inc - Key Competitors
- iCubate Inc - Key Employees
- iCubate Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- iCubate Inc, Recent Developments
- Aug 08, 2019: iCubate presents data on the iC-Myco Assay at the American Association of Clinical Chemistry Meeting
- Aug 02, 2019: iCubate earns FDA “breakthrough device” designation for latest assay
- Jul 23, 2019: Huntsville’s iCubate announces FDA clearance for innovative bloodstream infection testing
- Jul 12, 2019: Icubate earns FDA clearance for latest assay
- Jun 27, 2019: iCubate receives CE IVD mark for bloodstream infection assay
- Aug 23, 2017: iCubate Receives CE Mark for the iC-GPC Assay
- Aug 22, 2017: iCubate Receives CE Mark for the iC-GPC Assay for use on the iC-System
- Aug 10, 2017: iCubate Earns FDA Clearance for iC-GPC Assay A Unique Diagnostic Solution for the diagnosis of Bloodstream Infections
- Aug 10, 2017: iCubate Earns FDA Clearance for iC-System for the diagnosis of Bloodstream Infections
- Oct 06, 2016: iCubate forms Scientific Advisory Board
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- iCubate Inc Pipeline Products and Ongoing Clinical Trials Overview
- iCubate Inc Pipeline Products by Equipment Type
- iCubate Inc Pipeline Products by Indication
- iCubate Inc, Key Facts
- iCubate Inc, Major Products and Services
- iCubate Inc Number of Pipeline Products by Development Stage
- iCubate Inc Pipeline Products Summary by Development Stage
- iC-COVID19 Assay - Product Status
- iC-COVID19 Assay - Product Description
- iC-GPC Assay - Product Status
- iC-GPC Assay - Product Description
- iC-Myco Assay - Product Status
- iC-Myco Assay - Product Description
- iCubate Inc, Key Employees
- iCubate Inc, Joint Venture
- Glossary
- iCubate Inc Pipeline Products by Equipment Type
- iCubate Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aperiomics Inc
- DNA Electronics Inc
- T2 Biosystems Inc
